We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$12.4B
AUM Growth
+$271M
Cap. Flow
-$478M
Cap. Flow %
-3.86%
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$127M
2
GILD icon
Gilead Sciences
GILD
+$125M
3
PYPL icon
PayPal
PYPL
+$89.3M
4
UNH icon
UnitedHealth
UNH
+$88.1M
5
GE icon
GE Aerospace
GE
+$81.8M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$148M
2
KR icon
Kroger
KR
+$105M
3
COST icon
Costco
COST
+$94.8M
4
LRCX icon
Lam Research
LRCX
+$79.3M
5
CHTR icon
Charter Communications
CHTR
+$73.2M

Sector Composition

Rank Sector Weight
1 Healthcare 20.46%
2 Technology 16.23%
3 Industrials 15.74%
4 Consumer Discretionary 11.32%
5 Communication Services 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
51
Fortinet
FTNT
$120B
$79.1M 0.64%
10,713,320
+728,025
+7% +$5.09M
ICLR icon
52
Icon
ICLR
$12.2B
$77.5M 0.63%
1,001,700
-77,945
-7% -$5.86M
SBUX icon
53
Starbucks
SBUX
$118B
$77.3M 0.62%
1,428,638
-82,641
-5% -$4.62M
AVGO icon
54
Broadcom
AVGO
$1.87T
$75.1M 0.61%
4,353,470
+495,270
+13% +$8.28M
MA icon
55
Mastercard
MA
$500B
$75.1M 0.61%
737,739
-354,009
-32% -$33.9M
INFO
56
DELISTED
IHS Markit Ltd. Common Shares
INFO
$74.7M 0.6%
+1,989,265
New +$71.1M
MSCI icon
57
MSCI
MSCI
$41.8B
$74.2M 0.6%
884,019
-11,140
-1% -$947K
TMO icon
58
Thermo Fisher Scientific
TMO
$212B
$73.9M 0.6%
464,371
-122,013
-21% -$18.8M
INTC icon
59
Intel
INTC
$459B
$73M 0.59%
+1,934,989
New +$68.5M
WMGI
60
DELISTED
Wright Medical Group Inc
WMGI
$73M 0.59%
2,974,989
-50,588
-2% -$1.16M
NXST icon
61
Nexstar Media Group
NXST
$5.88B
$72.7M 0.59%
1,259,006
-24,790
-2% -$1.31M
TRU icon
62
TransUnion
TRU
$15.3B
$71.5M 0.58%
2,072,966
+429,115
+26% +$14.4M
ARMK icon
63
Aramark
ARMK
$14.9B
$71.1M 0.57%
2,587,949
-796,472
-24% -$21M
K
64
DELISTED
Kellanova
K
$69.8M 0.56%
959,823
+48,509
+5% +$3.71M
SPLK
65
DELISTED
Splunk Inc
SPLK
$69.4M 0.56%
1,182,527
+416,580
+54% +$25M
RHT
66
DELISTED
Red Hat Inc
RHT
$67.8M 0.55%
838,420
+110,759
+15% +$8.24M
BERY
67
DELISTED
Berry Global Group, Inc.
BERY
$66.3M 0.54%
1,646,947
+683,923
+71% +$26.8M
BKNG icon
68
Booking.com
BKNG
$149B
$65.9M 0.53%
1,118,875
-997,200
-47% -$55.6M
CB icon
69
Chubb
CB
$134B
$65.8M 0.53%
523,306
+520,989
+22,485% +$66.1M
SABR icon
70
Sabre
SABR
$779M
$64.3M 0.52%
2,283,165
+183,580
+9% +$5.12M
NBIX icon
71
Neurocrine Biosciences
NBIX
$16.9B
$63.6M 0.51%
1,255,995
-19,580
-2% -$975K
AVNT icon
72
Avient
AVNT
$3.43B
$61.3M 0.49%
1,812,117
+42,890
+2% +$1.48M
AMG icon
73
Affiliated Managers Group
AMG
$10.1B
$60M 0.48%
414,741
-6,347
-2% -$909K
EQIX icon
74
Equinix
EQIX
$102B
$59.9M 0.48%
166,215
-74,440
-31% -$27.6M
HDS
75
DELISTED
HD Supply Holdings, Inc.
HDS
$59.4M 0.48%
1,857,266
-49,432
-3% -$1.71M

Similar funds

Westfield Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.

  • Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
  • Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
  • Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
  • Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
  • Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
  • Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
  • Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.

Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.